Bioprinting solutions for end-stage renal disease

Written by Georgi Makin

Organovo Holdings, Inc (CA, USA) has announced a collaboration with Professor Melissa Little at the (Murdoch Children's Research Institute; Melbourne, Australia) and Ton Rabelink (Universiteit Leiden; Leiden, The Netherlands) for a project focused on the 3D bioprinting of stem cell-based therapeutic renal tissues. Organovo Holdings, Inc (CA, USA) has announced a collaboration with Professor Melissa Little  Murdoch Children's Research Institute; Melbourne, Australia) and Ton Rabelink (Universiteit Leiden; Leiden, The Netherlands) for a project focused on the 3D bioprinting of stem cell-based therapeutic renal tissues. “Partnerships with world-class institutions can accelerate groundbreaking work in finding cures for critical unmet disease needs...

To view this content, please register now for access

It's completely free